Exelixis (EXEL) Tops Q1 EPS by 25c, provides guidance
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $51.35 -1.08%
EPS Growth %: +13.3%
Financial Fact:
Contract: 4.63M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +13.3%
Financial Fact:
Contract: 4.63M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.62, $0.25 better than the analyst estimate of $0.37. Revenue for the quarter came in at $555.4 million versus the consensus estimate of $495.3 million.
GUIDANCE:
Exelixis sees FY2025 revenue of $2.25-2.35 billion, versus the consensus of $2.252 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
- Apollo Private Credit Fund caps redemptions at 5% - Bloomberg
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
